Could a statin help save babies from early delivery?
NCT ID NCT07098975
First seen Feb 24, 2026 · Last updated Jun 19, 2026 · Updated 18 times
Summary
This study tests whether a daily dose of pravastatin, a common heart medication, can safely prolong pregnancy in women diagnosed with severe early-onset preeclampsia or fetal growth restriction. The trial will include 154 pregnant women between 24 and 30 weeks of gestation, randomly assigned to receive either pravastatin or a placebo. The goal is to see if the drug can delay delivery and improve outcomes for both mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACENTAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clínic de Barcelona
NOT_YET_RECRUITINGBarcelona, Spain
-
Hospital de la Santa Creu i de Sant Pau
RECRUITINGBarcelona, 08025, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pravastatin 40 mg
What this could lead to
If it works, this could offer a way to safely prolong pregnancy in women with placental insufficiency, reducing complications from early delivery.
What could go wrong
This is a Phase 2 trial with only 154 participants, so results are preliminary. Statins are generally safe but not yet proven for this use in pregnancy.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.